0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Fragment Market Research Report 2026
Published Date: 2026-04-20
|
Report Code: QYRE-Auto-22N13363
Home | Market Reports | Science| Biological Sciences
Global Gene Fragment Market Research Report 2023
BUY CHAPTERS

Global Gene Fragment Market Research Report 2026

Code: QYRE-Auto-22N13363
Report
2026-04-20
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Fragment Market Size

The global Gene Fragment market was valued at US$ 360 million in 2025 and is anticipated to reach US$ 759 million by 2032, at a CAGR of 11.4% from 2026 to 2032.

Gene Fragment Market

Gene Fragment Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Gene Fragment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
This report delivers a comprehensive overview of the global Gene Fragment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Fragment. The Gene Fragment market size, estimates, and forecasts are provided in terms of sales volume (Million bp) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Fragment market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Fragment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Gene Fragment Market Report

Report Metric Details
Report Name Gene Fragment Market
Accounted market size in 2025 US$ 360 million
Forecasted market size in 2032 US$ 759 million
CAGR 11.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 0-999 bp
  • 1000-1999 bp
  • 2000-3999 bp
  • 4000+ bp
by Application
  • CRISPR-based Genome Editing
  • Antibody Engineering
  • Cloning Process
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, Twist Bioscience, Synbio Technologies, Bio Basic, BiOligo Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Gene Fragment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Gene Fragment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Gene Fragment Market growing?

Ans: The Gene Fragment Market witnessing a CAGR of 11.4% during the forecast period 2026-2032.

What is the Gene Fragment Market size in 2032?

Ans: The Gene Fragment Market size in 2032 will be US$ 759 million.

What is the market share of major companies in Gene Fragment Market?

Ans: The top five players hold a share over 70%.

What is the Gene Fragment Market share by region?

Ans: North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.

Who are the main players in the Gene Fragment Market report?

Ans: The main players in the Gene Fragment Market are Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, Twist Bioscience, Synbio Technologies, Bio Basic, BiOligo Biotechnology

What are the Application segmentation covered in the Gene Fragment Market report?

Ans: The Applications covered in the Gene Fragment Market report are CRISPR-based Genome Editing, Antibody Engineering, Cloning Process, Others

What are the Type segmentation covered in the Gene Fragment Market report?

Ans: The Types covered in the Gene Fragment Market report are 0-999 bp, 1000-1999 bp, 2000-3999 bp, 4000+ bp

1 Gene Fragment Market Overview
1.1 Product Definition
1.2 Gene Fragment by Type
1.2.1 Global Gene Fragment Market Value by Type: 2025 vs 2032
1.2.2 0-999 bp
1.2.3 1000-1999 bp
1.2.4 2000-3999 bp
1.2.5 4000+ bp
1.3 Gene Fragment by Application
1.3.1 Global Gene Fragment Market Value by Application: 2025 vs 2032
1.3.2 CRISPR-based Genome Editing
1.3.3 Antibody Engineering
1.3.4 Cloning Process
1.3.5 Others
1.4 Global Gene Fragment Market Size Estimates and Forecasts
1.4.1 Global Gene Fragment Revenue 2021–2032
1.4.2 Global Gene Fragment Sales 2021–2032
1.4.3 Global Gene Fragment Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Gene Fragment Market Competition by Manufacturers
2.1 Global Gene Fragment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Gene Fragment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Gene Fragment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Gene Fragment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Gene Fragment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Gene Fragment, Product Types and Applications
2.7 Global Key Manufacturers of Gene Fragment, Date of Entry into the Industry
2.8 Global Gene Fragment Market Competitive Situation and Trends
2.8.1 Global Gene Fragment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Gene Fragment Players Market Share by Revenue
2.8.3 Global Gene Fragment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gene Fragment Market Scenario by Region
3.1 Global Gene Fragment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Gene Fragment Sales by Region: 2021–2032
3.2.1 Global Gene Fragment Sales by Region: 2021–2026
3.2.2 Global Gene Fragment Sales by Region: 2027–2032
3.3 Global Gene Fragment Revenue by Region: 2021–2032
3.3.1 Global Gene Fragment Revenue by Region: 2021–2026
3.3.2 Global Gene Fragment Revenue by Region: 2027–2032
3.4 North America Gene Fragment Market Facts & Figures by Country
3.4.1 North America Gene Fragment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Gene Fragment Sales by Country (2021–2032)
3.4.3 North America Gene Fragment Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gene Fragment Market Facts & Figures by Country
3.5.1 Europe Gene Fragment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Gene Fragment Sales by Country (2021–2032)
3.5.3 Europe Gene Fragment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gene Fragment Market Facts & Figures by Region
3.6.1 Asia Pacific Gene Fragment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Gene Fragment Sales by Region (2021–2032)
3.6.3 Asia Pacific Gene Fragment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gene Fragment Market Facts & Figures by Country
3.7.1 Latin America Gene Fragment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Gene Fragment Sales by Country (2021–2032)
3.7.3 Latin America Gene Fragment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gene Fragment Market Facts & Figures by Country
3.8.1 Middle East and Africa Gene Fragment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Gene Fragment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Gene Fragment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gene Fragment Sales by Type (2021–2032)
4.1.1 Global Gene Fragment Sales by Type (2021–2026)
4.1.2 Global Gene Fragment Sales by Type (2027–2032)
4.1.3 Global Gene Fragment Sales Market Share by Type (2021–2032)
4.2 Global Gene Fragment Revenue by Type (2021–2032)
4.2.1 Global Gene Fragment Revenue by Type (2021–2026)
4.2.2 Global Gene Fragment Revenue by Type (2027–2032)
4.2.3 Global Gene Fragment Revenue Market Share by Type (2021–2032)
4.3 Global Gene Fragment Price by Type (2021–2032)
5 Segment by Application
5.1 Global Gene Fragment Sales by Application (2021–2032)
5.1.1 Global Gene Fragment Sales by Application (2021–2026)
5.1.2 Global Gene Fragment Sales by Application (2027–2032)
5.1.3 Global Gene Fragment Sales Market Share by Application (2021–2032)
5.2 Global Gene Fragment Revenue by Application (2021–2032)
5.2.1 Global Gene Fragment Revenue by Application (2021–2026)
5.2.2 Global Gene Fragment Revenue by Application (2027–2032)
5.2.3 Global Gene Fragment Revenue Market Share by Application (2021–2032)
5.3 Global Gene Fragment Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Company Information
6.1.2 Integrated DNA Technologies Description and Business Overview
6.1.3 Integrated DNA Technologies Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Integrated DNA Technologies Gene Fragment Product Portfolio
6.1.5 Integrated DNA Technologies Recent Developments/Updates
6.2 Thermo Scientific
6.2.1 Thermo Scientific Company Information
6.2.2 Thermo Scientific Description and Business Overview
6.2.3 Thermo Scientific Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Scientific Gene Fragment Product Portfolio
6.2.5 Thermo Scientific Recent Developments/Updates
6.3 Eurofins Scientific
6.3.1 Eurofins Scientific Company Information
6.3.2 Eurofins Scientific Description and Business Overview
6.3.3 Eurofins Scientific Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eurofins Scientific Gene Fragment Product Portfolio
6.3.5 Eurofins Scientific Recent Developments/Updates
6.4 GenScript Biotech
6.4.1 GenScript Biotech Company Information
6.4.2 GenScript Biotech Description and Business Overview
6.4.3 GenScript Biotech Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 GenScript Biotech Gene Fragment Product Portfolio
6.4.5 GenScript Biotech Recent Developments/Updates
6.5 Azenta Life Sciences
6.5.1 Azenta Life Sciences Company Information
6.5.2 Azenta Life Sciences Description and Business Overview
6.5.3 Azenta Life Sciences Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Azenta Life Sciences Gene Fragment Product Portfolio
6.5.5 Azenta Life Sciences Recent Developments/Updates
6.6 Twist Bioscience
6.6.1 Twist Bioscience Company Information
6.6.2 Twist Bioscience Description and Business Overview
6.6.3 Twist Bioscience Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Twist Bioscience Gene Fragment Product Portfolio
6.6.5 Twist Bioscience Recent Developments/Updates
6.7 Synbio Technologies
6.7.1 Synbio Technologies Company Information
6.7.2 Synbio Technologies Description and Business Overview
6.7.3 Synbio Technologies Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Synbio Technologies Gene Fragment Product Portfolio
6.7.5 Synbio Technologies Recent Developments/Updates
6.8 Bio Basic
6.8.1 Bio Basic Company Information
6.8.2 Bio Basic Description and Business Overview
6.8.3 Bio Basic Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bio Basic Gene Fragment Product Portfolio
6.8.5 Bio Basic Recent Developments/Updates
6.9 BiOligo Biotechnology
6.9.1 BiOligo Biotechnology Company Information
6.9.2 BiOligo Biotechnology Description and Business Overview
6.9.3 BiOligo Biotechnology Gene Fragment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 BiOligo Biotechnology Gene Fragment Product Portfolio
6.9.5 BiOligo Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gene Fragment Industry Chain Analysis
7.2 Gene Fragment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gene Fragment Production Mode & Process Analysis
7.4 Gene Fragment Sales and Marketing
7.4.1 Gene Fragment Sales Channels
7.4.2 Gene Fragment Distributors
7.5 Gene Fragment Customer Analysis
8 Gene Fragment Market Dynamics
8.1 Gene Fragment Industry Trends
8.2 Gene Fragment Market Drivers
8.3 Gene Fragment Market Challenges
8.4 Gene Fragment Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Gene Fragment Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Gene Fragment Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Gene Fragment Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Gene Fragment Sales (Million bp) of Key Manufacturers (2021–2026)
 Table 5. Global Gene Fragment Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Gene Fragment Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Gene Fragment Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Gene Fragment Average Price (USD/bp) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Gene Fragment, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Gene Fragment, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Gene Fragment, Product Types and Applications
 Table 12. Global Key Manufacturers of Gene Fragment, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gene Fragment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Gene Fragment Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gene Fragment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Gene Fragment Sales by Region (Million bp), 2021–2026
 Table 18. Global Gene Fragment Sales Market Share by Region (2021–2026)
 Table 19. Global Gene Fragment Sales by Region (Million bp), 2027–2032
 Table 20. Global Gene Fragment Sales Market Share by Region (2027–2032)
 Table 21. Global Gene Fragment Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Gene Fragment Revenue Market Share by Region (2021–2026)
 Table 23. Global Gene Fragment Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Gene Fragment Revenue Market Share by Region (2027–2032)
 Table 25. North America Gene Fragment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Gene Fragment Sales by Country (Million bp), 2021–2026
 Table 27. North America Gene Fragment Sales by Country (Million bp), 2027–2032
 Table 28. North America Gene Fragment Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Gene Fragment Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Gene Fragment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Gene Fragment Sales by Country (Million bp), 2021–2026
 Table 32. Europe Gene Fragment Sales by Country (Million bp), 2027–2032
 Table 33. Europe Gene Fragment Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Gene Fragment Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Gene Fragment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Gene Fragment Sales by Region (Million bp), 2021–2026
 Table 37. Asia Pacific Gene Fragment Sales by Region (Million bp), 2027–2032
 Table 38. Asia Pacific Gene Fragment Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Gene Fragment Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Gene Fragment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Gene Fragment Sales by Country (Million bp), 2021–2026
 Table 42. Latin America Gene Fragment Sales by Country (Million bp), 2027–2032
 Table 43. Latin America Gene Fragment Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Gene Fragment Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Gene Fragment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Gene Fragment Sales by Country (Million bp), 2021–2026
 Table 47. Middle East and Africa Gene Fragment Sales by Country (Million bp), 2027–2032
 Table 48. Middle East and Africa Gene Fragment Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Gene Fragment Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Gene Fragment Sales (Million bp) by Type (2021–2026)
 Table 51. Global Gene Fragment Sales (Million bp) by Type (2027–2032)
 Table 52. Global Gene Fragment Sales Market Share by Type (2021–2026)
 Table 53. Global Gene Fragment Sales Market Share by Type (2027–2032)
 Table 54. Global Gene Fragment Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Gene Fragment Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Gene Fragment Revenue Market Share by Type (2021–2026)
 Table 57. Global Gene Fragment Revenue Market Share by Type (2027–2032)
 Table 58. Global Gene Fragment Price (USD/bp) by Type (2021–2026)
 Table 59. Global Gene Fragment Price (USD/bp) by Type (2027–2032)
 Table 60. Global Gene Fragment Sales (Million bp) by Application (2021–2026)
 Table 61. Global Gene Fragment Sales (Million bp) by Application (2027–2032)
 Table 62. Global Gene Fragment Sales Market Share by Application (2021–2026)
 Table 63. Global Gene Fragment Sales Market Share by Application (2027–2032)
 Table 64. Global Gene Fragment Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Gene Fragment Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Gene Fragment Revenue Market Share by Application (2021–2026)
 Table 67. Global Gene Fragment Revenue Market Share by Application (2027–2032)
 Table 68. Global Gene Fragment Price (USD/bp) by Application (2021–2026)
 Table 69. Global Gene Fragment Price (USD/bp) by Application (2027–2032)
 Table 70. Integrated DNA Technologies Company Information
 Table 71. Integrated DNA Technologies Description and Business Overview
 Table 72. Integrated DNA Technologies Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 73. Integrated DNA Technologies Gene Fragment Product
 Table 74. Integrated DNA Technologies Recent Developments/Updates
 Table 75. Thermo Scientific Company Information
 Table 76. Thermo Scientific Description and Business Overview
 Table 77. Thermo Scientific Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 78. Thermo Scientific Gene Fragment Product
 Table 79. Thermo Scientific Recent Developments/Updates
 Table 80. Eurofins Scientific Company Information
 Table 81. Eurofins Scientific Description and Business Overview
 Table 82. Eurofins Scientific Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 83. Eurofins Scientific Gene Fragment Product
 Table 84. Eurofins Scientific Recent Developments/Updates
 Table 85. GenScript Biotech Company Information
 Table 86. GenScript Biotech Description and Business Overview
 Table 87. GenScript Biotech Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 88. GenScript Biotech Gene Fragment Product
 Table 89. GenScript Biotech Recent Developments/Updates
 Table 90. Azenta Life Sciences Company Information
 Table 91. Azenta Life Sciences Description and Business Overview
 Table 92. Azenta Life Sciences Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 93. Azenta Life Sciences Gene Fragment Product
 Table 94. Azenta Life Sciences Recent Developments/Updates
 Table 95. Twist Bioscience Company Information
 Table 96. Twist Bioscience Description and Business Overview
 Table 97. Twist Bioscience Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 98. Twist Bioscience Gene Fragment Product
 Table 99. Twist Bioscience Recent Developments/Updates
 Table 100. Synbio Technologies Company Information
 Table 101. Synbio Technologies Description and Business Overview
 Table 102. Synbio Technologies Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 103. Synbio Technologies Gene Fragment Product
 Table 104. Synbio Technologies Recent Developments/Updates
 Table 105. Bio Basic Company Information
 Table 106. Bio Basic Description and Business Overview
 Table 107. Bio Basic Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 108. Bio Basic Gene Fragment Product
 Table 109. Bio Basic Recent Developments/Updates
 Table 110. BiOligo Biotechnology Company Information
 Table 111. BiOligo Biotechnology Description and Business Overview
 Table 112. BiOligo Biotechnology Gene Fragment Sales (Million bp), Revenue (US$ Million), Price (USD/bp), and Gross Margin (2021–2026)
 Table 113. BiOligo Biotechnology Gene Fragment Product
 Table 114. BiOligo Biotechnology Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Gene Fragment Distributors List
 Table 118. Gene Fragment Customers List
 Table 119. Gene Fragment Market Trends
 Table 120. Gene Fragment Market Drivers
 Table 121. Gene Fragment Market Challenges
 Table 122. Gene Fragment Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gene Fragment
 Figure 2. Global Gene Fragment Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Gene Fragment Market Share by Type: 2025 & 2032
 Figure 4. 0-999 bp Product Picture
 Figure 5. 1000-1999 bp Product Picture
 Figure 6. 2000-3999 bp Product Picture
 Figure 7. 4000+ bp Product Picture
 Figure 8. Global Gene Fragment Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Gene Fragment Market Share by Application: 2025 & 2032
 Figure 10. CRISPR-based Genome Editing
 Figure 11. Antibody Engineering
 Figure 12. Cloning Process
 Figure 13. Others
 Figure 14. Global Gene Fragment Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Gene Fragment Market Size (US$ Million), 2021–2032
 Figure 16. Global Gene Fragment Sales (Million bp), 2021–2032
 Figure 17. Global Gene Fragment Average Price (USD/bp), 2021–2032
 Figure 18. Gene Fragment Report Years Considered
 Figure 19. Gene Fragment Sales Share by Manufacturers in 2025
 Figure 20. Global Gene Fragment Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Gene Fragment Players: Market Share by Revenue in Gene Fragment in 2025
 Figure 22. Gene Fragment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Gene Fragment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Gene Fragment Sales Market Share by Country (2021–2032)
 Figure 25. North America Gene Fragment Revenue Market Share by Country (2021–2032)
 Figure 26. United States Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Gene Fragment Sales Market Share by Country (2021–2032)
 Figure 29. Europe Gene Fragment Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Gene Fragment Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Gene Fragment Revenue Market Share by Region (2021–2032)
 Figure 37. China Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Gene Fragment Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Gene Fragment Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Gene Fragment Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Gene Fragment Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Gene Fragment Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Gene Fragment by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Gene Fragment by Type (2021–2032)
 Figure 56. Global Gene Fragment Price (USD/bp) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Gene Fragment by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Gene Fragment by Application (2021–2032)
 Figure 59. Global Gene Fragment Price (USD/bp) by Application (2021–2032)
 Figure 60. Gene Fragment Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India